Sterile Product Development of Poorly Water-Soluble Drugs

In this podcast, we discuss delivery modalities for sterile product development of poorly water-soluble drugs, with our special guest: Dr. Manish Mujal, Director of Product Development and CTM Manufacturing at Frontage Laboratories, Inc.

"*" indicates required fields

First Name*

Last Name*

Company*

State*

Country

Email*

Phone*

Please only hit the submit button once.

I AGREE*

By submitting this form I agree that Frontage may process my data in the manner described in Frontage’s Privacy Policy.

This field is for validation purposes and should be left unchanged.

Sterile Product Development of Poorly Water-Soluble Drugs

Resources to Consider

Sterile Nanoemulsion Product Development: Challenges and Future...

WebninarAnalytical Challenges for CMC Development of Cell and Gene...

CMC-Product Development & Manufacturing Integrated Solutions

NDA, 505b(2) and ANDA Product Development Services

GMP Analytical Testing in Gene Therapy Products

Guidelines for Developmental and Reproductive Toxicity (DART) Testing

Microbiological Testing Considerations for Pharmaceutical Products

Meeting public health and regulatory demands for next generation...

In Vitro BE Study in ANDA Drug Product Development

Evaluating Emerging Tobacco Products and Their Potential Impact on...

CMC-Product Development Services

CMC GMP Analytical Testing for New Chemical Entities and Commercial...